CTNAV II : Multicentric Evaluation of IMACTIS-CT Navigation System
NCT ID: NCT01896219
Last Updated: 2018-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
464 participants
INTERVENTIONAL
2013-12-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of the SPECT-CT Scan SUVspect in the New Generation of Gamma-cameras With Semiconductor
NCT03414021
Impact of New Interventional Imaging Modality Use on Patient Radiation Exposure in Transarterial Chemoembolization
NCT03698643
Dynamic Contrast Enhancement Computed Tomography Based Technic to Assess Gastro Intestinal Wall Perfusion : Feasibility Study
NCT03367065
Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning
NCT07305103
Dose-Quality Study in the Temporal Bone Computed Tomography in Routine Care
NCT06827106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gesture performed under control tomodensitometric (CT)
Conventional
CT
Reference method for gestures (carried out under CT) guidance
Gesture performed under Navigation-assisted procedure (NAV)
Use of the IMACTIS-CT® Navigation System
Navigation station (IMACTIS-CT®)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Navigation station (IMACTIS-CT®)
CT
Reference method for gestures (carried out under CT) guidance
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient for whom an indication of diagnostic or therapeutic percutaneous interventional gesture in the thoraco-abdominal level under CT guidance is prescribed
* Patient affiliated to social security or similarly regime
* Patient signed consent for participation in the study.
Exclusion Criteria
* Patient who presents ferromagnetic foreign bodies intracorporeal close to the working zone of Radiologist, and that can interact with the medical device
* Pregnant women and lactating mothers
* Ward of court or under guardianship
* Person deprived of freedom by judicial or administrative decision
* Person under legal protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivan Bricault, Pr
Role: PRINCIPAL_INVESTIGATOR
Radiology Departement - University Hospital of Grenoble
Eric Delabrousse, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Besançon
Bruno Lapuyade, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Pascal Lacombe, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Garches
Laurent Lemaitre, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Lille
Valérie Laurent, Pr
Role: PRINCIPAL_INVESTIGATOR
CHU NANCY
Jean-Yves Gauvrit, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Rennes
Olivier Favelle, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Tours
Eric De Kerviler, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Saint-Louis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Besançon, Doubs, France
University Hospital
Bordeaux, Gironde, France
Ambroise Paré University Hospital
Boulogne-Billancourt, Hauts-de-Seine, France
University Hospital
Rennes, Ille-et-Vilaine, France
University Hospital
Tours, Indre-et-Loire, France
University Hospital
Grenoble, Isère, France
University Hospital
Nancy, Meuse, France
University Hospital
Lille, Nord, France
University Hospital of Saint-Louis
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rouchy RC, Moreau-Gaudry A, Chipon E, Aubry S, Pazart L, Lapuyade B, Durand M, Hajjam M, Pottier S, Renard B, Logier R, Orry X, Cherifi A, Quehen E, Kervio G, Favelle O, Patat F, De Kerviler E, Hughes C, Medici M, Ghelfi J, Mounier A, Bricault I. Evaluation of the clinical benefit of an electromagnetic navigation system for CT-guided interventional radiology procedures in the thoraco-abdominal region compared with conventional CT guidance (CTNAV II): study protocol for a randomised controlled trial. Trials. 2017 Jul 6;18(1):306. doi: 10.1186/s13063-017-2049-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A00539-36
Identifier Type: OTHER
Identifier Source: secondary_id
DCIC 12 29
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.